California Says 'Yes' to Stem-Cell Research
By Jonathan Knight,
Nature
| 11. 03. 2004
$3-billion initiative will fund creation of human cell lines
George W. Bush has won the presidential election. But Republicans are not the only ones celebrating the poll results: biologists who wish to pursue human embryonic stem-cell research have also had good news. All they have to do is move to California, if they aren't already there, and apply for a share of the $3 billion that voters have just approved for their field.
By 59% to 41% of votes, Californians said "yes" to Proposition 71, the California Stem Cell Research and Cures Initiative, which will raise around $300 million a year for a decade through bond sales.
The money will pay for research that has not been eligible for government money since 9 August 2001, when President George W. Bush limited federal spending on human embryonic stem-cell research to cell lines in existence as of that date. The creation of new cell lines involves the destruction of a days-old human embryo.
Most biomedical researchers believe that the number of lines available under the 2001 rule will be inadequate to realize the potential of stem-cell research, which might give insight...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...